tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrea Tan, 19 are a BUY (61.29%), 10 are a HOLD (32.26%), 2 are a SELL (6.45%).
Analyst Andrea Tan, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 33% that have a potential upside of 30.37% achieved within 85 days.
Andrea Tan’s has documented 61 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TARS, Tarsus Pharmaceuticals at 15-Nov-2024.
Analyst best performing recommendations are on CDAK (CODIAK BIOSCIENCES ).
The best stock recommendation documented was for CDAK (CODIAK BIOSCIENCES ) at 8/31/2022. The price target of $2 was fulfilled within 1 day with a profit of $0.15 (6.98%) receiving and performance score of 69.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1.4
$1.39 (13900.00%)
$2
2 years 1 months 14 days ago
(07-Nov-2022)
1/3 (33.33%)
$0.6 (75.00%)
1
Buy
$7
$6.99 (69900.00%)
$24
2 years 5 months 16 days ago
(05-Jul-2022)
2/6 (33.33%)
$4.12 (143.06%)
16
Which stock is Andrea Tan is most bullish on?
Which stock is Andrea Tan is most reserved on?
What Year was the first public recommendation made by Andrea Tan?
